COVID-19 Impact on Global Chimeric Antigen Receptor Cell Therapy Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Chimeric Antigen Receptor Cell Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Acute Leukemia
1.5.3 Non-hodgkin's Lymphoma
1.5.4 Multiple Myeloma
1.5.5 Transplant Rejection
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Chimeric Antigen Receptor Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Chimeric Antigen Receptor Cell Therapy Industry
1.6.1.1 Chimeric Antigen Receptor Cell Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chimeric Antigen Receptor Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Chimeric Antigen Receptor Cell Therapy Market Perspective (2015-2026)
2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions
2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Chimeric Antigen Receptor Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Market Size
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2019
3.3 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
3.4 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
3.5 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
6.2 Chimeric Antigen Receptor Cell Therapy Key Players in North America (2019-2020)
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
7.2 Chimeric Antigen Receptor Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
8.2 Chimeric Antigen Receptor Cell Therapy Key Players in China (2019-2020)
8.3 China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
8.4 China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
9.2 Chimeric Antigen Receptor Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
10.2 Chimeric Antigen Receptor Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
11.2 Chimeric Antigen Receptor Cell Therapy Key Players in India (2019-2020)
11.3 India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
11.4 India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size (2015-2020)
12.2 Chimeric Antigen Receptor Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen Inc
13.1.1 Amgen Inc Company Details
13.1.2 Amgen Inc Business Overview and Its Total Revenue
13.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020))
13.1.5 Amgen Inc Recent Development
13.2 Autolus Therapeutics Plc
13.2.1 Autolus Therapeutics Plc Company Details
13.2.2 Autolus Therapeutics Plc Business Overview and Its Total Revenue
13.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
13.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.2.5 Autolus Therapeutics Plc Recent Development
13.3 Beijing Immunochina Medical Science & Technology Co Ltd
13.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
13.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview and Its Total Revenue
13.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
13.4 Bellicum Pharmaceuticals Inc
13.4.1 Bellicum Pharmaceuticals Inc Company Details
13.4.2 Bellicum Pharmaceuticals Inc Business Overview and Its Total Revenue
13.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.4.5 Bellicum Pharmaceuticals Inc Recent Development
13.5 Bristol-Myers Squibb Co
13.5.1 Bristol-Myers Squibb Co Company Details
13.5.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
13.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.5.5 Bristol-Myers Squibb Co Recent Development
13.6 bluebird bio Inc
13.6.1 bluebird bio Inc Company Details
13.6.2 bluebird bio Inc Business Overview and Its Total Revenue
13.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.6.5 bluebird bio Inc Recent Development
13.7 CARsgen Therapeutics Ltd
13.7.1 CARsgen Therapeutics Ltd Company Details
13.7.2 CARsgen Therapeutics Ltd Business Overview and Its Total Revenue
13.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.7.5 CARsgen Therapeutics Ltd Recent Development
13.8 Celgene Corp
13.8.1 Celgene Corp Company Details
13.8.2 Celgene Corp Business Overview and Its Total Revenue
13.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
13.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.8.5 Celgene Corp Recent Development
13.9 Cell Medica Ltd
13.9.1 Cell Medica Ltd Company Details
13.9.2 Cell Medica Ltd Business Overview and Its Total Revenue
13.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
13.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.9.5 Cell Medica Ltd Recent Development
13.10 Cellular Biomedicine Group Inc
13.10.1 Cellular Biomedicine Group Inc Company Details
13.10.2 Cellular Biomedicine Group Inc Business Overview and Its Total Revenue
13.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
13.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
13.10.5 Cellular Biomedicine Group Inc Recent Development
13.11 Celularity Inc
10.11.1 Celularity Inc Company Details
10.11.2 Celularity Inc Business Overview and Its Total Revenue
10.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.11.5 Celularity Inc Recent Development
13.12 Celyad SA
10.12.1 Celyad SA Company Details
10.12.2 Celyad SA Business Overview and Its Total Revenue
10.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
10.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.12.5 Celyad SA Recent Development
13.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Company Details
10.13.2 Daiichi Sankyo Co Ltd Business Overview and Its Total Revenue
10.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.13.5 Daiichi Sankyo Co Ltd Recent Development
13.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Company Details
10.14.2 Fosun Pharmaceutical AG Business Overview and Its Total Revenue
10.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
10.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.14.5 Fosun Pharmaceutical AG Recent Development
13.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Company Details
10.15.2 Gilead Sciences Inc Business Overview and Its Total Revenue
10.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.15.5 Gilead Sciences Inc Recent Development
13.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview and Its Total Revenue
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
13.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Company Details
10.17.2 Hangzhou Converd Co Ltd Business Overview and Its Total Revenue
10.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.17.5 Hangzhou Converd Co Ltd Recent Development
13.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
10.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview and Its Total Revenue
10.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
13.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Company Details
10.19.2 HRAIN Biotechnology Co Ltd Business Overview and Its Total Revenue
10.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.19.5 HRAIN Biotechnology Co Ltd Recent Development
13.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Company Details
10.20.2 Juno Therapeutics Inc Business Overview and Its Total Revenue
10.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.20.5 Juno Therapeutics Inc Recent Development
13.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Company Details
10.21.2 Kite Pharma Inc Business Overview and Its Total Revenue
10.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.21.5 Kite Pharma Inc Recent Development
13.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Company Details
10.22.2 Nanjing Legend Biotech Co Ltd Business Overview and Its Total Revenue
10.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.22.5 Nanjing Legend Biotech Co Ltd Recent Development
13.23 NantKwest Inc
10.23.1 NantKwest Inc Company Details
10.23.2 NantKwest Inc Business Overview and Its Total Revenue
10.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.23.5 NantKwest Inc Recent Development
13.24 Nkarta Inc
10.24.1 Nkarta Inc Company Details
10.24.2 Nkarta Inc Business Overview and Its Total Revenue
10.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.24.5 Nkarta Inc Recent Development
13.25 Novartis AG
10.25.1 Novartis AG Company Details
10.25.2 Novartis AG Business Overview and Its Total Revenue
10.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
10.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.25.5 Novartis AG Recent Development
13.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Company Details
10.26.2 Ono Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.26.5 Ono Pharmaceutical Co Ltd Recent Development
13.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview and Its Total Revenue
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
13.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Company Details
10.28.2 Sorrento Therapeutics Inc Business Overview and Its Total Revenue
10.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.28.5 Sorrento Therapeutics Inc Recent Development
13.29 Takara Bio Inc
10.29.1 Takara Bio Inc Company Details
10.29.2 Takara Bio Inc Business Overview and Its Total Revenue
10.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
10.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020)
10.29.5 Takara Bio Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Chimeric Antigen Receptor Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
Table 3. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four Chimeric Antigen Receptor Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Chimeric Antigen Receptor Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Chimeric Antigen Receptor Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Chimeric Antigen Receptor Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Chimeric Antigen Receptor Cell Therapy Players
Table 23. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2019)
Table 26. Global Chimeric Antigen Receptor Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
Table 29. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Chimeric Antigen Receptor Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 39. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 41. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 45. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 51. China Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 53. China Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 57. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 69. India Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 71. India Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Chimeric Antigen Receptor Cell Therapy Market Share (2019-2020)
Table 75. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2015-2020)
Table 79. Amgen Inc Company Details
Table 80. Amgen Inc Business Overview
Table 81. Amgen Inc Product
Table 82. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 83. Amgen Inc Recent Development
Table 84. Autolus Therapeutics Plc Company Details
Table 85. Autolus Therapeutics Plc Business Overview
Table 86. Autolus Therapeutics Plc Product
Table 87. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 88. Autolus Therapeutics Plc Recent Development
Table 89. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 90. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 91. Beijing Immunochina Medical Science & Technology Co Ltd Product
Table 92. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 93. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 94. Bellicum Pharmaceuticals Inc Company Details
Table 95. Bellicum Pharmaceuticals Inc Business Overview
Table 96. Bellicum Pharmaceuticals Inc Product
Table 97. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 98. Bellicum Pharmaceuticals Inc Recent Development
Table 99. Bristol-Myers Squibb Co Company Details
Table 100. Bristol-Myers Squibb Co Business Overview
Table 101. Bristol-Myers Squibb Co Product
Table 102. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Co Recent Development
Table 104. bluebird bio Inc Company Details
Table 105. bluebird bio Inc Business Overview
Table 106. bluebird bio Inc Product
Table 107. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 108. bluebird bio Inc Recent Development
Table 109. CARsgen Therapeutics Ltd Company Details
Table 110. CARsgen Therapeutics Ltd Business Overview
Table 111. CARsgen Therapeutics Ltd Product
Table 112. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 113. CARsgen Therapeutics Ltd Recent Development
Table 114. Celgene Corp Business Overview
Table 115. Celgene Corp Product
Table 116. Celgene Corp Company Details
Table 117. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 118. Celgene Corp Recent Development
Table 119. Cell Medica Ltd Company Details
Table 120. Cell Medica Ltd Business Overview
Table 121. Cell Medica Ltd Product
Table 122. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 123. Cell Medica Ltd Recent Development
Table 124. Cellular Biomedicine Group Inc Company Details
Table 125. Cellular Biomedicine Group Inc Business Overview
Table 126. Cellular Biomedicine Group Inc Product
Table 127. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 128. Cellular Biomedicine Group Inc Recent Development
Table 129. Celularity Inc Company Details
Table 130. Celularity Inc Business Overview
Table 131. Celularity Inc Product
Table 132. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 133. Celularity Inc Recent Development
Table 134. Celyad SA Company Details
Table 135. Celyad SA Business Overview
Table 136. Celyad SA Product
Table 137. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 138. Celyad SA Recent Development
Table 139. Daiichi Sankyo Co Ltd Company Details
Table 140. Daiichi Sankyo Co Ltd Business Overview
Table 141. Daiichi Sankyo Co Ltd Product
Table 142. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 143. Daiichi Sankyo Co Ltd Recent Development
Table 144. Fosun Pharmaceutical AG Company Details
Table 145. Fosun Pharmaceutical AG Business Overview
Table 146. Fosun Pharmaceutical AG Product
Table 147. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 148. Fosun Pharmaceutical AG Recent Development
Table 149. Gilead Sciences Inc Company Details
Table 150. Gilead Sciences Inc Business Overview
Table 151. Gilead Sciences Inc Product
Table 152. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 153. Gilead Sciences Inc Recent Development
Table 154. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 155. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 156. Guangzhou Anjie Biomedical Technology Co Ltd Product
Table 157. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 158. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 159. Hangzhou Converd Co Ltd Company Details
Table 160. Hangzhou Converd Co Ltd Business Overview
Table 161. Hangzhou Converd Co Ltd Product
Table 162. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 163. Hangzhou Converd Co Ltd Recent Development
Table 164. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 165. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 166. Hebei Senlang Biotechnology Inc Ltd Product
Table 167. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 168. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 169. HRAIN Biotechnology Co Ltd Company Details
Table 170. HRAIN Biotechnology Co Ltd Business Overview
Table 171. HRAIN Biotechnology Co Ltd Product
Table 172. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 173. HRAIN Biotechnology Co Ltd Recent Development
Table 174. Juno Therapeutics Inc Company Details
Table 175. Juno Therapeutics Inc Business Overview
Table 176. Juno Therapeutics Inc Product
Table 177. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 178. Juno Therapeutics Inc Recent Development
Table 179. Kite Pharma Inc Company Details
Table 180. Kite Pharma Inc Business Overview
Table 181. Kite Pharma Inc Product
Table 182. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 183. Kite Pharma Inc Recent Development
Table 184. Nanjing Legend Biotech Co Ltd Company Details
Table 185. Nanjing Legend Biotech Co Ltd Business Overview
Table 186. Nanjing Legend Biotech Co Ltd Product
Table 187. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 188. Nanjing Legend Biotech Co Ltd Recent Development
Table 189. NantKwest Inc Company Details
Table 190. NantKwest Inc Business Overview
Table 191. NantKwest Inc Product
Table 192. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2015-2020) (Million US$)
Table 193. NantKwest Inc Recent Development
Table 194. Nkarta Inc Company

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs